Prudential Financial’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $570K | Buy |
70,010
+4,275
| +7% | +$34.8K | ﹤0.01% | 1894 |
|
|
2025
Q1 | $516K | Buy |
65,735
+10,430
| +19% | +$81.9K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $823K | Sell |
55,305
-600
| -1% | -$8.93K | ﹤0.01% | 1646 |
|
|
2024
Q3 | $855K | Sell |
55,905
-2,550
| -4% | -$39K | ﹤0.01% | 1967 |
|
|
2024
Q2 | $890K | Sell |
58,455
-4,850
| -8% | -$73.9K | ﹤0.01% | 1899 |
|
|
2024
Q1 | $1.2M | Buy |
63,305
+1,050
| +2% | +$19.8K | ﹤0.01% | 1733 |
|
|
2023
Q4 | $1.19M | Sell |
62,255
-13,920
| -18% | -$266K | ﹤0.01% | 1731 |
|
|
2023
Q3 | $1.37M | Sell |
76,175
-2,080
| -3% | -$37.3K | ﹤0.01% | 1601 |
|
|
2023
Q2 | $1.59M | Buy |
78,255
+14,273
| +22% | +$290K | ﹤0.01% | 1557 |
|
|
2023
Q1 | $1.17M | Sell |
63,982
-1,865
| -3% | -$34K | ﹤0.01% | 1661 |
|
|
2022
Q4 | $1.36M | Sell |
65,847
-245
| -0.4% | -$5.07K | ﹤0.01% | 1531 |
|
|
2022
Q3 | $1.73M | Buy |
66,092
+4,605
| +7% | +$120K | ﹤0.01% | 1418 |
|
|
2022
Q2 | $1.56M | Buy |
61,487
+38,140
| +163% | +$966K | ﹤0.01% | 1544 |
|
|
2022
Q1 | $737K | Sell |
23,347
-308
| -1% | -$9.72K | ﹤0.01% | 2019 |
|
|
2021
Q4 | $957K | Sell |
23,655
-175
| -0.7% | -$7.08K | ﹤0.01% | 1900 |
|
|
2021
Q3 | $831K | Buy |
23,830
+380
| +2% | +$13.3K | ﹤0.01% | 1912 |
|
|
2021
Q2 | $644K | Sell |
23,450
-21,081
| -47% | -$579K | ﹤0.01% | 2044 |
|
|
2021
Q1 | $1.25M | Buy |
44,531
+342
| +0.8% | +$9.6K | ﹤0.01% | 1708 |
|
|
2020
Q4 | $1.15M | Sell |
44,189
-16,980
| -28% | -$441K | ﹤0.01% | 1684 |
|
|
2020
Q3 | $1.05M | Sell |
61,169
-19,125
| -24% | -$328K | ﹤0.01% | 1622 |
|
|
2020
Q2 | $1.99M | Buy |
80,294
+55,914
| +229% | +$1.38M | ﹤0.01% | 1340 |
|
|
2020
Q1 | $338K | Sell |
24,380
-43,330
| -64% | -$601K | ﹤0.01% | 2028 |
|
|
2019
Q4 | $684K | Buy |
+67,710
| New | +$684K | ﹤0.01% | 1977 |
|